KGW-TV profiles Annette Adkins, the second person in the country to undergo a new procedure to treat an intractable form of epilepsy. Kim Burchiel, M.D., says: “It’s a revolutionary technique in that we’re not removing something, but we’re actually implanting something that will grow and take root in the brain and will suppress the seizure activity.”

In a video interview with EndocrineToday, Maria Fleseriu, M.D., reviews the pituitary and adrenal research highlights presented at the annual meeting of the European Society of Endocrinology.

Researchers at the OHSU Knight Cancer Institute have secured more than $1 million to equip and expand a newly formed Knight Cancer Precision Biofabrication Hub to develop organs, bone for pioneering research into cancer, and more. Luiz Bertassoni, D.D.S., Ph.D., says: “The real focus is to recreate cancer tissues using these fabrication techniques. This will let us dissect the complexities of cancers and understand the contribution of each one of these cells and tumor building blocks.”

In a video interview with OncLive, Alexandra Sokolova, M.D., discusses key findings from a phase 3 clinical trial in patients with metastatic castration-resistant prostate cancer.

Gordon Mills, M.D., Ph.D., joins the oncology-focused Scientific Advisory Board of Nuvation Bio, Inc.

Researchers at the OHSU Knight Cancer Institute have secured more than $1 million to equip and expand a newly formed Knight Cancer Precision Biofabrication Hub to develop organs, bone for pioneering research into cancer, and more. Luiz Bertassoni, D.D.S., Ph.D., says: “The real focus is to recreate cancer tissues using these fabrication techniques. This will let us dissect the complexities of cancers and understand the contribution of each one of these cells and tumor building blocks."

The Oregonian covers the current obstacles facing the Oregon Legislature, including disagreements on abortion and gender-affirming care. The story notes medical providers including Planned Parenthood and OHSU require patients 14 or younger to have parents’ consent for abortion care.

Justin Leitenberger, M.D., discusses Mohs surgery in treating patients with melanoma: “Melanoma care is inherently multidisciplinary, and most surgeons can be an integral part of an expert team to provide the best outcome for these patients."

Hiromichi Park, D.O., presents findings from a recent study suggesting that patients hospitalized with COVID-19 received antibiotics for potential secondary bacterial infections without clinical indications suggesting they could benefit from the treatment.

In an Inverse story on the potential FDA approval of an over-the-counter birth control pill, Alison Edelman, M.D., says it’s a grassroots effort that’s been years, if not decades, in the making.